Eris Lifesciences Introduces DEMELAN NEXA Serum: Next-Generation Melanophagy-Focused Approach for Melasma Management in India Dr. Bhumika Maikhuri6 April 2026 10:45 AM ISTRecognizing the evolving understanding of pigmentation biology, Eris Lifesciences has launched DEMELAN NEXA Serum, a next-generation...
Eris Lifesciences Asked to Revise Phase IV Protocol for Dapagliflozin, Gliclazide, Metformin FDC Susmita Roy2 April 2026 6:02 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Eris...
Eris Lifesciences Acquires Velbiom's Probiotic Portfolio for Rs 50 Crore Parthika Patel23 March 2026 3:00 PM ISTMumbai: Eris Lifesciences Limited has announced the acquisition of the branded probiotic business of Velbiom Probiotics Private Limited through a...
NPPA Fixes Retail Rates for 36 Key Drugs Like Atorvastatin, Dapagliflozin, Gemcitabine Susmita Roy3 Feb 2026 5:59 PM ISTNew Delhi: Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India,...
Eris Lifesciences Moves to Complete Swiss Parenterals Acquisition sheeba farhat17 Jan 2026 3:34 PM ISTNew Delhi: Eris Lifesciences Limited has completed the acquisition of the remaining 30 percent stake in Swiss Parenterals Limited, making it a wholly...
Eris Lifesciences to buy balance 30 percent stake in Swiss Parenterals for Rs 423 crore Ruchika Sharma26 Nov 2025 1:52 PM ISTMumbai: Eris Lifesciences Limited has announced that its Board of Directors has approved the acquisition of the balance 30 percent stake in Swiss...
Eris Lifesciences Secures CDSCO Panel Nod to Conduct BE Study on Dapagliflozin, Pioglitazone, Metformin FDC Susmita Roy15 Sept 2025 1:14 PM ISTNew Delhi: Eris Lifesciences has got the go ahead from the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control...
Eris Lifesciences receives ANVISA approval for Ahmedabad Sterile Injectable facility Ruchika Sharma27 Aug 2025 3:17 PM ISTMumbai: Following the Anvisa approval of an oral dose manufacturing unit, Eris Lifesciences Limited, an Indian branded formulations...
Eris Lifesciences Slapped Rs 17 Crore GST Notice Over Novartis Zomelis Deal Farhat Nasim27 Aug 2025 10:00 AM ISTNew Delhi: Eris Lifesciences Limited has disclosed that it has received a show cause-cum-demand notice amounting to Rs16.84 crore from the Directorate...
Eris Lifesciences receives ANVISA approval at its Ahmedabad campus Ruchika Sharma25 Aug 2025 5:00 PM ISTMumbai: Eris Lifesciences Limited, an Indian branded formulations manufacturing company, has announced that a manufacturing unit in its Ahmedabad...
Eris Gets CDSCO Panel Nod To Dapagliflozin-Bisoprolol-Sacubitril Valsartan Combo Kit, Phase IV Trial Mandated Parthika Patel23 July 2025 7:41 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Cardiovascular division of the Central Drugs Standard Control Organisation (CDSCO) has...
NPPA fixes retail prices of 71 formulations including Empagliflozin, Metformin, Sitagliptin and Glimepiride Ruchika Sharma8 July 2025 5:45 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of 71 formulations under Drugs (Prices Control) Order,...
